Results 11 to 20 of about 210,559 (109)

Bioprosthetic Aortic Valve Fracture During Valve-in-valve Transcatheter Aortic Valve Implantation [PDF]

open access: yesInterventional Cardiology: Reviews, Research, Resources, 2019
The limited durability of surgical bioprostheses, combined with an ageing population, has led to an increasing demand for replacing degenerated bioprosthetic surgical heart valves, which is projected to increase. Valve-in-valve transcatheter aortic valve
John Phineas O’Donnell   +1 more
doaj   +2 more sources

Early bioprosthetic valve calcification with alfacalcidol supplementation [PDF]

open access: yesJournal of Cardiothoracic Surgery, 2013
We report a case of early bioprosthetic valve calcification in a 76 year-old woman who had received supplementation with alfacalcidol, an analogue of vitamin D, for 3 years after her initial valve replacement.
Takano Tamaki   +6 more
doaj   +3 more sources

Transcatheter heart valve in valve implantation with Edwards SAPIEN bioprosthetic valve for different degenerated bioprosthetic valve positions (First Iranian ViV report with mid-term follow up) [PDF]

open access: yesJournal of Cardiovascular and Thoracic Research, 2017
Introduction: After early successful experience with transcatheter aortic valve replacement (TAVR), concept of transcatheter implantation of a new valve within a failing bioprosthetic valve emerged. Valve-in-valve (ViV) implantation seems to be a simpler
Ali Mohammad Haji Zeinali   +4 more
doaj   +2 more sources

Effects of Bioprosthetic Valve Fracturing on Valve-in-Valve Transcatheter Aortic Valve Implantation Transvalvular Gradients [PDF]

open access: yesTexas Heart Institute Journal
Background: Valve-in-valve (ViV) transcatheter aortic valve implantation (TAVI) is quickly becoming a routine and effective means by which to treat degenerated bioprosthetic valves.
Osama Hallak, MD   +6 more
doaj   +3 more sources

Development of methods for the tissue engineering of cardiac valves using mesenchymal stem cells [PDF]

open access: yes, 2004
Cardiac valve replacement is the second most common heart operation in the Western World. Valve replacements currently available are poorly adapted for use in young patients who typically require multiple re-operations as they grow, resulting in ...
Knight, Richard Lewis
core   +7 more sources

Structure-function relationships in the aortic valve [PDF]

open access: yes, 2012
PhDGlobally, heart valve dysfunction constitutes a large portion of the cardiovascular disease load, causing high rates of mortality in European and industrialized countries.
Anssari-Benam, Afshin
core   +4 more sources

Meta-Analysis of Bioprosthetic Valve Thrombosis after Transcatheter Aortic Valve Implantation. [PDF]

open access: yes, 2021
Bioprosthetic valve thrombosis may complicate transcatheter aortic valve implantation (TAVI). This meta-analysis sought to evaluate the prevalence and clinical impact of subclinical leaflet thrombosis (SLT) and clinical valve thrombosis (CVT) after TAVI.
Rheude, Tobias   +12 more
core   +1 more source

Production and characterisation of acellular porcine pulmonary heart valve conduits [PDF]

open access: yes, 2011
Cardiac valve replacement is the second most common heart operation. Currently available replacement heart valves all have limitations. This study aimed to produce and characterise a decellularised, biocompatible porcine pulmonary root conduit for use ...
Luo, Ji
core   +6 more sources

Efficacy and safety of edoxaban in patients early after surgical bioprosthetic valve implantation or valve repair: A randomized clinical trial

open access: yes, 2023
Objective: Early warfarin anticoagulation is recommended in patients undergoing surgical bioprosthetic valve implantation or valve repair. It is unclear whether non-vitamin K antagonist oral anticoagulants can be a full alternative to warfarin.
이삭   +9 more
core   +1 more source

Modern understanding of mechanisms of bioprosthetic valve structural degeneration: a literature review

open access: yesРоссийский кардиологический журнал, 2018
Bioprosthetic valves are often used to replace diseased heart valves. They differ from mechanical valves by optimal hemodynamic parameters and low thrombogenicity.
A. E. Kostyunin   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy